Use of a HEHEHE Purification Tag Instead of a Hexahistidine Tag Improves Biodistribution of Affibody Molecules Site-Specifically Labeled with 99mTc, 111In and 125I

被引:56
作者
Hofstrom, Camilla [2 ]
Orlova, Anna [1 ]
Altai, Mohamed [1 ]
Wangsell, Fredrik [3 ]
Graslund, Torbjorn [2 ]
Tolmachev, Vladimir [1 ]
机构
[1] Uppsala Univ, Div Biomed Radiat Sci, Rudbeck Lab, Uppsala, Sweden
[2] Royal Inst Technol, Dept Mol Biotechnol, Stockholm, Sweden
[3] Uppsala Univ, Dept Med Chem, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
ANTI-HER2; AFFIBODY; HER2; EXPRESSION; HER2-EXPRESSING TUMORS; RECOMBINANT PROTEINS; MALIGNANT-TUMORS; PEPTIDE; AFFINITY; TECHNETIUM; SCAFFOLD; THERAPY;
D O I
10.1021/jm200065e
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Affibody molecules are a class of small (similar to 7 kDa) robust scaffold proteins suitable for radionuclide molecular imaging in vivo. The attachment of a hexahistidine (His(6))-tag to the Affibody molecule allows facile purification by immobilized metal ion affinity chromatography (IMAC) but leads to high accumulation of radioactivity in the liver. Earlier, we have demonstrated that replacement of the His(6)- tag with the negatively charged histidine-glutamate-histidine-glutamate-histidine-glutamate (HEHEHE)-tag permits purification of Affibody molecules by IMAC, enables labeling with [Tc-99m(CO)(3)](+), and provides low hepatic accumulation of radioactivity. In this study, we compared the biodistribution of cysteine-containing Affibody molecules site-specifically labeled with In-111, Tc-99m, and I-125 at the C-terminus, having a His(6)-tag at the N- or C-terminus or a HEHEHE-tag at the N-terminus. We show that the use of a HEHEHE-tag provides appreciable reduction of hepatic radioactivity, especially for radiometal labels. We hope that this information can also be useful for development of other scaffold protein-based imaging agents.
引用
收藏
页码:3817 / 3826
页数:10
相关论文
共 41 条
[1]
ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO
[2]
2-7
[3]
Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules [J].
Ahlgren, Sara ;
Orlova, Anna ;
Rosik, Daniel ;
Sandstrom, Mattias ;
Sjoberg, Anna ;
Basstrup, Barbo ;
Widmark, Olof ;
Fant, Gunilla ;
Feldwisch, Joachim ;
Tolmachev, Vladimir .
BIOCONJUGATE CHEMISTRY, 2008, 19 (01) :235-243
[4]
Radionuclide Molecular Imaging Using Affibody Molecules [J].
Ahlgren, Sara ;
Tolmachev, Vladimir .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (06) :581-589
[5]
Targeting of HER2-Expressing Tumors Using 111In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold [J].
Ahlgren, Sara ;
Orlova, Anna ;
Wallberg, Helena ;
Hansson, Monika ;
Sandstrom, Mattias ;
Lewsley, Richard ;
Wennborg, Anders ;
Abrahmsen, Lars ;
Tolmachev, Vladimir ;
Feldwisch, Joachim .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (07) :1131-1138
[6]
Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine [J].
Ahlgren, Sara ;
Andersson, Kristofer ;
Tolmachev, Vladimir .
NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (05) :539-546
[7]
Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine [J].
Ahlgren, Sara ;
Wallberg, Helena ;
Tran, Thuy A. ;
Widstrom, Charles ;
Hjertman, Magnus ;
Abrahmsen, Lars ;
Berndorff, Dietmar ;
Dinkelborg, Ludger M. ;
Cyr, John E. ;
Feldwisch, Joachim ;
Orlova, Anna ;
Tolmachev, Vladimir .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (05) :781-789
[8]
Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules [J].
Baum, Richard P. ;
Prasad, Vikas ;
Mueller, Dirk ;
Schuchardt, Christiane ;
Orlova, Anna ;
Wennborg, Anders ;
Tolmachev, Vladimir ;
Feldwisch, Joachim .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (06) :892-897
[9]
Berndorff D, 2006, J NUCL MED, V47, P1707
[10]
IMMOBILIZED-METAL AFFINITY CHROMATOGRAPHY (IMAC): A REVIEW [J].
Block, Helena ;
Maertens, Barbara ;
Spriestersbach, Anne ;
Brinker, Nicole ;
Kubicek, Jan ;
Fabis, Roland ;
Labahn, Joerg ;
Schaefer, Frank .
GUIDE TO PROTEIN PURIFICATION, SECOND EDITION, 2009, 463 :439-473